BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+4.36%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.24B
AUM Growth
+$7.24B
(+2.4%)
Cap. Flow
+$197M
Cap. Flow
% of AUM
2.72%
Top 10 Holdings %
Top 10 Hldgs %
34.84%
Holding
226
New
18
Increased
74
Reduced
41
Closed
9
Top Buys
| 1 |
Relay Therapeutics
RLAY
|
$55.4M |
| 2 |
Exact Sciences
EXAS
|
$31M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$22.1M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$20.8M |
| 5 |
MTEM
Molecular Templates, Inc.
MTEM
|
$16.9M |
Top Sells
| 1 |
Pacific Biosciences
PACB
|
$44M |
| 2 |
Halozyme
HALO
|
$33.2M |
| 3 |
Evolent Health
EVH
|
$21.8M |
| 4 |
AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
|
$20.4M |
| 5 |
Medtronic
MDT
|
$15.2M |
Sector Composition
| 1 | Healthcare | 95.98% |
| 2 | Industrials | 0.6% |
| 3 | Technology | 0.53% |
| 4 | Communication Services | 0.41% |
| 5 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Teladoc Health
TDOC
$1.37B
| $26.6M | 0.37% |
121,354
-29,945
| -20% | -$6.57M |
|
77
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $25.7M | 0.36% |
1,403,400
+246,000
| +21% | +$4.51M |
|
78
Glaukos
GKOS
$5.5B
| $25.5M | 0.35% |
515,754
+21,943
| +4% | +$1.09M |
|
|
CHNG
79
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $24.6M | 0.34% |
1,697,939
+242,699
| +17% | +$3.52M |
|
80
Quanterix
QTRX
$211M
| $24.4M | 0.34% |
723,674
+246,159
| +52% | +$8.31M |
|
81
Masimo
MASI
$7.59B
| $24.1M | 0.33% |
102,153
+4,612
| +5% | +$1.09M |
|
82
Penumbra
PEN
$10.6B
| $23.6M | 0.33% |
121,194
+23,042
| +23% | +$4.48M |
|
83
Wave Life Sciences
WVE
$1.53B
| $22.1M | 0.31% |
2,602,858
| – | – |
|
|
HMSY
84
DELISTED
HMS Holdings Corp.
HMSY
| $22M | 0.3% |
916,984
+102,720
| +13% | +$2.46M |
|
85
Kezar Life Sciences
KZR
$28.9M
| $21.9M | 0.3% |
4,533,148
+291,208
| +7% | +$1.41M |
|
86
iRhythm Technologies
IRTC
$5.46B
| $21.6M | 0.3% |
90,518
-2,622
| -3% | -$624K |
|
87
Omnicell
OMCL
$1.5B
| $20.8M | 0.29% |
278,421
+76,290
| +38% | +$5.7M |
|
88
Globus Medical
GMED
$8.27B
| $20.3M | 0.28% |
409,735
+62,006
| +18% | +$3.07M |
|
|
SILK
89
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $20.2M | 0.28% |
300,619
+55,281
| +23% | +$3.72M |
|
90
10x Genomics
TXG
$1.74B
| $19.2M | 0.27% |
153,989
+30,912
| +25% | +$3.85M |
|
91
Health Catalyst
HCAT
$239M
| $19.1M | 0.26% |
521,896
+172,727
| +49% | +$6.32M |
|
92
Q32 Bio
QTTB
$20.9M
| $18.6M | 0.26% |
1,737,122
| – | – |
|
93
Guardant Health
GH
$8.41B
| $18.2M | 0.25% |
162,383
+35,822
| +28% | +$4M |
|
94
Illumina
ILMN
$15.8B
| $18.1M | 0.25% |
58,547
-37,500
| -39% | -$11.6M |
|
|
GNMK
95
DELISTED
GenMark Diagnostics, Inc
GNMK
| $17.9M | 0.25% |
1,263,811
-225,473
| -15% | -$3.2M |
|
|
NVRO
96
DELISTED
NEVRO CORP.
NVRO
| $16.8M | 0.23% |
120,569
+8,807
| +8% | +$1.23M |
|
97
NeoGenomics
NEO
$1.13B
| $15.7M | 0.22% |
426,892
-58,578
| -12% | -$2.16M |
|
|
AMED
98
DELISTED
Amedisys
AMED
| $14.6M | 0.2% |
61,851
+708
| +1% | +$167K |
|
99
Phreesia
PHR
$1.88B
| $13.7M | 0.19% |
426,956
+49,787
| +13% | +$1.6M |
|
100
Zai Lab
ZLAB
$3.68B
| $13.4M | 0.19% |
161,200
-13,900
| -8% | -$1.16M |
|